1-4 of 4
Shan-Shan Chen
Close
Sort by
Journal Articles

Imatinib Mesylate Is Superior to Allogeneic Hematopoietic Stem Cell Transplantation As the First-Line Therapy for Patients with Chronic Myeloid Leukemia in the Early Chronic Phase

Qian Jiang, Lan-Ping Xu, Dai-Hong Liu, Kai-Yan Liu, Bin Jiang, Xiao-hui Zhang, Yu Wang, Shan-Shan Chen, Xiao-Dong Mo, Xiang-Yu Zhao, Huan Chen, Yu-Hong Chen, Wei Han, Hao Jiang, Ya-Zhen Qin, Yan-Rong Liu, Yue-yun Lai, Hong-Xia Shi, Meng Lv, Xiao Jun Huang
Journal: Blood
Blood (2011) 118 (21): 162.
https://doi.org/10.1182/blood.V118.21.162.162
Published: 2011
Journal Articles

Imatinib mesylate versus allogeneic hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in the accelerated phase

Clinical Trials & Observations
Qian Jiang, Lan-Ping Xu, Dai-Hong Liu, Kai-Yan Liu, Shan-Shan Chen, Bin Jiang, Hao Jiang, Huan Chen, Yu-Hong Chen, Wei Han, Xiao-Hui Zhang, Yu Wang, Ya-Zhen Qin, Yan-Rong Liu, Yue-Yun Lai, Xiao-Jun Huang
Journal: Blood
Blood (2011) 117 (11): 3032–3040.
https://doi.org/10.1182/blood-2010-09-308510
Published: 2011
Journal Articles

Imatinib Mesylate Versus Allogeneic HSCT for Patients with Chronic Myelogenous Leukemia In Accelerated Phase: A Single Center Experience In China After a 9-Year Follow-up

Qian Jiang, Lan-Ping Xu, Dai-Hong Liu, Kaiyan Liu, MD, PhD, Shan-Shan Chen, Bin Jiang, MD, Hao Jiang, Huan Chen, Yu-Hong Chen, Wei Han, Xiao-hui Zhang, Yu Wang, Ya-Zhen Qin, Yan-Rong Liu, Yue-yun Lai, Xiao Jun Huang
Journal: Blood
Blood (2010) 116 (21): 2347.
https://doi.org/10.1182/blood.V116.21.2347.2347
Published: 2010
Journal Articles

Tetra-arsenic tetra-sulfide for the treatment of acute promyelocytic leukemia: a pilot report

Clinical Trials & Observations
Dao-Pei Lu, Jing-Ying Qiu, Bin Jiang, Qin Wang, Kai-Yan Liu, Yan-Rong Liu, Shan-Shan Chen
Journal: Blood
Blood (2002) 99 (9): 3136–3143.
https://doi.org/10.1182/blood.V99.9.3136
Published: 2002